Iterum Therapeutics
ITRM
#10106
Rank
NZ$41.81 M
Marketcap
NZ$0.79
Share price
1.55%
Change (1 day)
-80.02%
Change (1 year)

Earnings for Iterum Therapeutics (ITRM)

Earnings in 2025 (TTM): -NZ$36.19 Million

According to Iterum Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$37.91 Million, an increase over its 2023 earnings that were of -NZ$62.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Iterum Therapeutics from 2017 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$36.19 Million-4.55%
2024 -NZ$37.91 Million-39.41%
2023 -NZ$62.57 Million-13.03%
2022 -NZ$71.94 Million-51.03%
2021 -NZ$0.15 Billion135.87%
2020 -NZ$62.29 Million-64.48%
2019 -NZ$0.18 Billion33.65%
2018 -NZ$0.14 Billion159.97%
2017 -NZ$50.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion 589.06%๐Ÿ‡บ๐Ÿ‡ธ USA